See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Amazon
Artificial Intelligence
Natural Disasters
Floods
Donald Trump
Social Media
Taxes
Education
Crime
Infrastructure
Republican Party
Cricket
Published • loading... • Updated

mRNA Flu Vaccine Meets Primary End Point Among Older Adults

Summary by Pharmacy Times
Moderna's mRNA-1010 flu vaccine shows promising efficacy, especially for older adults, addressing the urgent need for better influenza prevention.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Pharmacy TimesPharmacy Times

mRNA Flu Vaccine Meets Primary End Point Among Older Adults

Moderna's mRNA-1010 flu vaccine shows promising efficacy, especially for older adults, addressing the urgent need for better influenza prevention.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Pharmacy Times broke the news in on Tuesday, July 8, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Vaccinations icon

Vaccinations

Influenza icon

Influenza

News
For You
SearchBlindspotLocal